UBS AM’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $111M | Buy |
|
|||||
|
2025
Q2 | $4.04M | Sell |
|
|||||
|
2025
Q1 | $93.2M | Sell |
|
|||||
|
2024
Q4 | $128M | Sell |
|
|||||
|
2024
Q3 | $148M | Buy |
|
|||||
|
2024
Q2 | $119M | Buy |
|
|||||
|
2024
Q1 | $146M | Sell |
|
|||||
|
2023
Q4 | $162M | Sell |
|
|||||
|
2023
Q3 | $206M | Buy |
|
|||||
|
2023
Q2 | $256M | Hold |
|
|||||
|
2023
Q1 | $256M | Buy |
|
|||||
|
2022
Q4 | $176M | Buy |
|
|||||
|
2022
Q3 | $164M | Buy |
|
|||||
|
2022
Q2 | $186M | Buy |
|
|||||
|
2022
Q1 | $195M | Buy |
|
|||||
|
2021
Q4 | $260M | Sell |
|
|||||
|
2021
Q3 | $267M | Sell |
|
|||||
|
2021
Q2 | $239M | Sell |
|
|||||
|
2021
Q1 | $219M | Sell |
|
|||||
|
2020
Q4 | $294M | Buy |
|
|||||
|
2020
Q3 | $199M | Sell |
|
|||||
|
2020
Q2 | $186M | Buy |
|
|||||
|
2020
Q1 | $128M | Sell |
|
|||||
|
2019
Q4 | $163M | Buy |
|
|||||
|
2019
Q3 | $139M | Buy |
|
|||||
|
2019
Q2 | $124M | Buy |
|
|||||
|
2019
Q1 | $118M | Sell |
|
|||||
|
2018
Q4 | $96.3M | Buy |
|
|||||
|
2018
Q3 | $79.7M | Sell |
|
|||||
|
2018
Q2 | $79.1M | Sell |
|
|||||
|
2018
Q1 | $70.1M | Sell |
|
|||||
|
2017
Q4 | $85.8M | Sell |
|
|||||
|
2017
Q3 | $91.4M | Sell |
|
|||||
|
2017
Q2 | $96.7M | Sell |
|
|||||
|
2017
Q1 | $87.1M | Sell |
|
|||||
|
2016
Q4 | $85.1M | Buy |
|
|||||
|
2016
Q3 | $70.1M | Sell |
|
|||||
|
2016
Q2 | $64.2M | Buy |
|
|||||
|
2016
Q1 | $56.8M | Sell |
|
|||||
|
2015
Q4 | $65.3M | Sell |
|
|||||
|
2015
Q3 | $77.4M | Sell |
|
|||||
|
2015
Q2 | $88.8M | Buy |
|
|||||
|
2015
Q1 | $74.9M | Sell |
|
|||||
|
2014
Q4 | $67.8M | Sell |
|
|||||
|
2014
Q3 | $64.5M | Sell |
|
|||||
|
2014
Q2 | $70.1M | Sell |
|
|||||
|
2014
Q1 | $76.6M | Sell |
|
|||||
|
2013
Q4 | $78.4M | Buy |
|
|||||
|
2013
Q3 | $66.4M | Sell |
|
|||||
|
2013
Q2 | $66.4M | Buy |
|